Denoël Paule, Vanderstraeten Jacques, Mols Pierre, Pepersack Thierry
Emergency Service, Europe Hospital, 1040 Brussels, Belgium.
Centre de Recherche en Santé Environnementale et en Santé du Travail, Ecole de Santé Publique, Université Libre de Bruxelles, 1070 Brussels, Belgium.
J Aging Res. 2014;2014:693740. doi: 10.1155/2014/693740. Epub 2014 Sep 10.
Several studies have reported underprescription of anticoagulants in atrial fibrillation (AF). We conducted an observational study on 142 out of a total of 995 consecutive ≥75 years old patients presenting AF (14%) when admitted in an emergency unit of a general hospital, in search of geriatric characteristics that might be associated with the underprescription of anticoagulation therapy (mostly antivitamin K at the time of the study). The following data was collected from patients presenting AF: medical history including treatment and comorbidities, CHADS2 score, ISAR scale (frailty), Lawton's scale (ADL), GDS scale (mood status), MUST (nutrition), and blood analysis (INR, kidney function, and albumin). Among those patients for who anticoagulation treatment was recommended (73%), only 61% were treated with it. In the group with anticoagulation therapy, the following characteristics were observed more often than in the group without such therapy: a recent (≤6 months) hospitalization and medical treatment including digoxin or based on >3 different drugs. Neither the value of the CHADS2 score, nor the geriatric characteristics could be correlated with the presence or the absence of an anticoagulation therapy. More research is thus required to identify and clarify the relative importance of patient-, physician-, and health care system-related hurdles for the prescription of oral anticoagulation therapy in older patients with AF.
多项研究报告了心房颤动(AF)患者抗凝剂处方不足的情况。我们对一家综合医院急诊科收治的995例连续≥75岁的房颤患者中的142例(14%)进行了一项观察性研究,以寻找可能与抗凝治疗(研究时主要是抗维生素K)处方不足相关的老年特征。从房颤患者中收集了以下数据:病史,包括治疗情况和合并症、CHADS2评分、ISAR量表(衰弱程度)、Lawton量表(日常生活活动能力)、GDS量表(情绪状态)、MUST(营养状况)以及血液分析(国际标准化比值(INR)、肾功能和白蛋白)。在那些被推荐进行抗凝治疗的患者中(73%),只有61%接受了治疗。在接受抗凝治疗的组中,与未接受此类治疗的组相比,以下特征更为常见:近期(≤6个月)住院以及包括地高辛或基于三种以上不同药物的药物治疗。CHADS2评分的值以及老年特征均与是否接受抗凝治疗无关。因此,需要更多研究来确定并阐明老年房颤患者口服抗凝治疗处方中与患者、医生和医疗保健系统相关的障碍的相对重要性。